Gentian develops and manufactures high quality, in vitro diagnostic (IVD) reagents for a wide range of clinical chemistry analysers. Our product lines of laboratory tests, for diverse diagnostic targets, provide high accuracy and fast results for both human and veterinary healthcare.
We believe that our innovative and accurate diagnostic products lead to improved laboratory efficiency, better decision making in the clinical setting and therefore can improve patients’ outcomes.
Gentian performs production, R&D, marketing and distribution from our headquarters in Moss, Norway and our representative offices. We serve the global market for human and veterinary medical diagnostic tests via our OEM partners and key distributors as well as directly through Gentian Diagnostics AB, our Swedish based distribution subsidiary. Our approach is collaborative and adaptable, without compromising quality, in order to meet our customers needs.
Our reagents are developed using avian antibodies and our proprietary NanoSense technology. Importantly, they can be adapted for use on all major clinical chemistry analysers. Our current products cover renal function and inflammatory diseases. Our pipeline of products covers diverse diagnostic areas including cardiovascular diseases, viral infections and cancer diagnostics.
Quality is at the core of our everyday work and is a driving factor in achieving diagnostic efficiency.
All companies in the Gentian Diagnostics group continuously evaluate and improve their operations to increase the satisfaction of our customers, employees, owners and the markets we operate in. We make sure that every new product meets the highest performance standards.
Gentian integrates its Quality Management System and Design Control Standards within all areas of the company, including Research, Development and Production.
The Gentian Diagnostics companies have interdisciplinary and international teams working on global solutions to improve clinical accuracy.